A Pharmacokinetic and Safety Study of TAK-925 in Participants With Idiopathic Hypersomnia
Condition: Idiopathic Hypersomnia Interventions: Drug: TAK-925; Drug: TAK-925 Placebo Sponsor: Millennium Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2019 Category: Research Source Type: clinical trials
